Celltrion Healthcare Co., Ltd. v. Janssen Biotech, Inc.
1:14-cv-11613
Overview
Parties
Defendant
Plaintiff
Celltrion Healthcare Co., Ltd. Operating Company
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Massachusetts (mad)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd.
Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7598083
Chemically defined media compositions
|
Filed: 2005-10-27
Issued: 2009-10-06
|
Expiring Soon (79 days)
+468d PTA
Expires: 2027-02-07
|
Patent Enforceability & Injunction Risk Assessment
Narrowing Window β Imminent expiration makes injunctive relief unlikely to be granted.
High PTA (+468 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
20
Dispositive
9
Granted
0
Denied
0
Pending / Review
20
Motions by Category
Key Dispositive Motions & Rulings